Estrofurate

This classification denotes a steroidal estrogen with the molecular formula C24H26O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0CDE7T54KW, chemically known as 21,23-epoxy-19,24-dinor-17alpha-chola-1,3,5(10),7,20,22-hexaene-3,17-diol 3-acetate but generally known as estrofurate, which bears US NIH Compound Identifier 66360. European Medicines Agency schedules Estrofurate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07250MIG. The term ESTROFURATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). ESTROFURATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule estrofurate under HS 29372300 and SITC 54153. As of Q4 2014, ESTROFURATE remains the US FDA Preferred Term for this commodity. Estrofurate bears US NLM identifiers UMLS ID C1880558 and NCI Concept Code C65543. SMILES: OC1(C2(C(CC1)C1=CCc3c(C1CC2)ccc(OC(=O)C)c3)C)c1ccoc1.